Drawing for ONCOGUIDE

USPTO serial 88281102

ONCOGUIDE

Reviewed by CopyMark Law Group

Reg. 7178643Status 700Registered
Filing date
Status date
Registration date
Oct 3, 2023
Examiner
KELLEY, EVELYN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ONCOGUIDE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Virginia Wolk Marino

Virginia Wolk Marino CROWELL & MORINGP.O. BOX 10395CHICAGO, IL 60610UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical reagents, other than for medical or veterinary use; chemical preparations, for scientific purposes, other than for medical or veterinary use; Biochemicals for scientific or research use, namely, reagents for testing biological samples; biochemical reagents for non-medical use; enzymes for scientific and research use; Testing reagents and preparations, namely, biological sample testing reagents used for non-medical purposes; Reagents for genetic test, namely, gene mutation tests comprised of reagents for non-medical use; diluents for diluting samples or reagents for scientific or laboratory purposes, other than for medical or veterinary use; Buffer solutions used for testing of biological samples other than for medical or veterinary use; Surfactants for pretreatment of samples for genetic testing; chemical reference materials for scientific or research use; Quality control materials, namely, fluids, frozen or lyophilized materials for testing and calibrating scientific or laboratory apparatus; Emulsifying agents used for preparing emulsion for genetic testing for non-medical purposes; chemical products for forming emulsion; chemical products for breaking emulsion; magnetic beads for use in scientific or research analysis for nucleic acid isolation and/or purification; DNA polymerase for scientific research purposes; Chemical preparations containing DNA fragments for scientific purposes; Chemical reagents for cell analysis tests for non-medical use; Chemical reagents for protein analysis tests for non-medical use; Detergents for laboratory use; Detergents for apparatus and instruments used in laboratoriesACTIVE—
003Detergents for cleaning apparatus and instruments for genetic testing; Chemical cleaning solutions for genetic testing; cleaning preparations; Cleaning solutions for apparatus and instruments for genetic testing; cleaning preparations for apparatus and instrumentsACTIVE—
005Diagnostic reagents and diagnostic preparations for medical or veterinary use; Chemical reagents for medical or veterinary use; chemical preparations for medical or veterinary purposes, namely, for testing of biological samples; Biochemical reagents for medical use, namely, diagnostic reagents for medicinal use; enzymes for use in medical analysis; Testing reagents and preparations for medical or veterinary use, namely, medical diagnostic reagents and assays for testing of body fluids including blood and/or tissues; reagents for genetic testing for medical or veterinary purposes; preparations for detecting mutations in genes for medical or veterinary purposes; diagnostic biomarker reagents for medical or veterinary use; Diluents for medical or veterinary use, namely, for diluting samples or reagents used in genetic testing; Quality control materials, namely, fluids, frozen or lyophilized materials for testing and calibrating genetic testing analyzers for medical or veterinary use; Quality control standard solutions and materials for testing and calibrating medical or veterinary apparatus, namely, artificial DNA or synthetic nucleic acid; detergents for medical or veterinary use; Cleaning solutions for medical or veterinary use, namely, for cleaning medical apparatus and instruments; Cleaning preparations for medical or veterinary use, namely, for cleaning medical apparatus and instruments; Medical diagnostic solutions, namely, sheath solutions for use in medical analysis; magnetic beads for use in medical analysis for nucleic acid isolation and/or purification; DNA polymerase for use in medical analysis; Chemical preparations containing DNA fragments for use in medical analysis for genetic testing; Chemical reagents for cell analysis tests for medical or clinical use; Chemical reagents for protein analysis tests for medical or clinical useACTIVE—
009Testing apparatus and instruments for scientific, research or laboratory use, namely, instruments for genetic analysis; Laboratory apparatus and instruments, namely, instruments for genetic analysis; Measuring or testing machines and instruments for use in genetic testing; laboratory apparatus and furniture for use in genetic testing; Flow cytometers providing cell and particle analysis, detection, or counting for scientific and laboratory use; particle analyzers for scientific, research or laboratory use; genetic analyzer for scientific, research or laboratory use; particle counters, namely, flow cytometers and image analyzers for scientific, research or laboratory use; Genetic testing apparatus and instruments for scientific, research or laboratory use, namely, downloadable computer software for scientific analysis of genetic sequences, and devices for detecting gene mutation; Gene amplification analyzers for scientific, research or laboratory use, namely, for genetic analysis; DNA sequencer for scientific, research or laboratory use, namely, devices and/or downloadable computer software reading DNA base sequencing; biological sample pretreatment apparatus and instruments for scientific, research or laboratory use; measurement sample preparation apparatus and instruments for scientific, research or laboratory use; pretreatment apparatus and instruments for genetic testing for scientific, research or laboratory use; Testing instruments for genetic testing, namely, thermal cyclers and/or flow cytometers for scientific, research or laboratory use; laboratory instruments for extracting nucleic acid in a biological sample for scientific, research or laboratory use; microplates for laboratory experiment; test tubes for scientific, research or laboratory use; pipette tips for scientific, research or laboratory use; Computers; Downloadable computer programs for use in the field of scientific and laboratory analysis; Downloadable computer program for use in the field of medical, clinical or diagnostic analysis; Electronic downloadable publications in the nature of magazines and manuals in the field of genetic testing; Downloadable computer programs for genetic, cell and protein analysis; Cell analysis apparatus and instruments for scientific, research or laboratory use, namely, flow cytometers, flow-based analyzers and image analyzers; Protein analysis apparatus and instruments for scientific, research or laboratory use, namely, flow cytometers, flow-based analyzers and image analyzersACTIVE—
010Medical and veterinary apparatus and instruments for use in sample analysis procedures; Testing apparatus and instruments for medical or clinical use for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of genetic testing; diagnostic apparatus and instruments for medical or clinical use for diagnosing gene mutation; Flow cytometers for diagnostic medical or clinical use; flow-based particle analyzers providing cell and particle analysis, detection, or counting for medical or clinical use; particle counters, namely, flow cytometers or flow-based analyzers, for medical or clinical use; genetic testing apparatus and instruments for medical or clinical diagnostic use, namely, apparatus for medical diagnostic testing in the field of gene analysis; gene amplification analyzers for detecting gene mutation for medical or clinical use; DNA sequencer for medical or clinical use, namely, for gene analysis; biological sample pretreatment apparatus and instruments for medical or clinical use; measurement sample preparation apparatus and instruments for medical or clinical use; pretreatment apparatus and instruments for genetic testing for medical or clinical use, namely, body fluids including blood and/or tissue pretreatment apparatus and instruments for medical use; Dropping pipettes for medical purposes; measuring apparatus and instruments for use in medical analysis for detecting gene mutation; medical containers especially adapted and designed for use with samples for in vitro diagnosis sold empty; medical sampling bottles especially designed for use in medical analysis, namely, for collecting and/or preserving biological samples; medical devices, namely, disposable beakers especially designed for use in medical analysis, namely, blood or tissue analysis, not for laboratory use; cell analysis apparatus and instruments for medical or clinical use, namely, flow cytometers, flow-based analyzers; protein analysis apparatus and instruments for medical or clinical use, namely, flow cytometers, flow-based analyzersACTIVE—
042Scientific and technological research in the fields of genetic testing and oncology; scientific research, scientific analysis, and design relating thereto in the field of genetic testing and oncology; design and development of diagnostic products and service; diagnostic and analytical testing services for others, namely, performing genetic testing and diagnostic testing in the field of oncology; clinical trial services; testing services to detect or quantify gene mutations, gene variations, gene amplification, gene loss and gene fusion for scientific and research purposes; molecular biomarker testing services for scientific and research purposes; DNA sequencing services for scientific and research purposes; scientific and technological research to assist in the design, development and management of in-vitro diagnostic tests for scientific and research purposes; testing services for research in gene analysis; testing services to assist in treatment decision-making in diseases for scientific and research purposes; testing services for companion diagnostics for scientific and research purposes; testing and research relating to cell analysis for scientific purposes; Testing and research relating to protein analysis for scientific purposes; clinical laboratory testing services and reporting of results for scientific and research purposes; providing online non-downloadable computer programs for use in the field of scientific and laboratory analysis; providing online non-downloadable computer program for use in the field of medical, clinical or diagnostic analysis; providing online non-downloadable computer programs for genetic, cell and protein analysisACTIVE—
044Providing medical information; medical diagnostic testing and reporting services pertaining to the monitoring, diagnosis and treatment of disease; medical diagnostic services to assist in the design, development and management of in-vitro diagnostic tests; providing medical data/information to healthcare professionals; testing services to provide information regarding disease conditions and disease prevention for medical purposes; diagnostic services, namely, medical diagnostic testing for diseases and disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 3, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 3, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 28, 2023DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Jul 13, 2023IUCNNOTICE OF ALLOWANCE CANCELLED—
Jul 13, 2023D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Feb 10, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 9, 2023EX5GSOU EXTENSION 5 GRANTED—
Feb 9, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 24, 2023EXT5SOU EXTENSION 5 FILED—
Jan 24, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 3, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 3, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Aug 3, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 3, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 30, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 28, 2022EX4GSOU EXTENSION 4 GRANTED—
Jul 28, 2022EXT4SOU EXTENSION 4 FILED—
Jul 28, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 12, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 10, 2022EX3GSOU EXTENSION 3 GRANTED—
Feb 10, 2022EXT3SOU EXTENSION 3 FILED—
Feb 10, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 26, 2022DOCKASSIGNED TO EXAMINER—
Aug 23, 2021DOCKASSIGNED TO EXAMINER—
Jul 23, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 21, 2021EX2GSOU EXTENSION 2 GRANTED—
Jul 21, 2021EXT2SOU EXTENSION 2 FILED—
Jul 21, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 4, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 2, 2021EX1GSOU EXTENSION 1 GRANTED—
Feb 2, 2021EXT1SOU EXTENSION 1 FILED—
Feb 2, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 15, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 21, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 21, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 1, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 18, 2020PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 10, 2020ALIEASSIGNED TO LIE—
Jun 5, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 5, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jun 5, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 5, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 5, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 3, 2020ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 26, 2020PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
May 12, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 7, 2020XAECEXAMINER'S AMENDMENT ENTERED—
May 7, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 7, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
May 7, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 17, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 16, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 16, 2020ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Nov 12, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Nov 12, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Nov 12, 2019CNSLSUSPENSION LETTER WRITTEN—
Oct 23, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 23, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 23, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 23, 2019ALIEASSIGNED TO LIE—
Oct 17, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 17, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 16, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 13, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 13, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 13, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 10, 2019DOCKASSIGNED TO EXAMINER—
Feb 21, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 1, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance